Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2024 04:00 ET | Source: iOmx Therapeutics AG

iOmx Therapeutics Initiates Phase Ib with OMX-0407

Data from the successful Phase Ia dose escalation study showed that OMX-0407 monotherapy demonstrated a favorable safety profile and signs of anti-tumor activity, with one durable complete response in...